JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB176523

Anti-IGF1 antibody [7973]

Be the first to review this product! Submit a review

|

(9 Publications)

Mouse Monoclonal IGF1 antibody. Suitable for IHC-P and reacts with Human samples. Cited in 9 publications. Immunogen corresponding to Full Length Protein corresponding to Human IGF1.

View Alternative Names

IBP1, IGF-1, IGF1, Insulin-like growth factor 1, Insulin-like growth factor I, Mechano growth factor, Somatomedin-C, IGF-I, MGF

2 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IGF1 antibody [7973] (AB176523)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IGF1 antibody [7973] (AB176523)

Immunohistochemical analysis of Formalin Fixed Parafin-embedded normal Human kidney tissue labeling IGF1 with ab176523 at 1ug/ml.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IGF1 antibody [7973] (AB176523)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IGF1 antibody [7973] (AB176523)

Immunohistochemical analysis of Formalin Fixed Parafin-embedded normal Human kidney tissue labeling IGF1 with ab176523 at 1ug/ml.

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

7973

Isotype

IgG1

Carrier free

No

Reacts with

Human

Applications

IHC-P

applications

Immunogen

Full Length Protein corresponding to Human IGF1. The exact immunogen used to generate this antibody is proprietary information.

P05019

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1 µg/mL", "IHCP-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein G
Purification notes
ab176523 is purifed from tissue culture supernatant.
Storage buffer
Preservative: 0.03% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The insulin-like growth factor 1 or IGF1 is a protein hormone that plays an important mechanical role in growth and development. Alternative names for IGF1 include somatomedin C. This protein has a mass of approximately 7.6 kDa and is mainly produced by the liver. IGF1 is expressed in a range of tissues including muscle bone and cartilage reflecting its importance in various physiological processes. Its production is stimulated by growth hormone and it acts in an autocrine and paracrine manner to exert its effects.
Biological function summary

IGF1 stimulates growth and proliferation of cells most notably impacting the development of the skeletal system and the regulation of apoptosis. It is not part of a larger protein complex but it interacts closely with IGF1 receptor to execute its functions. By binding to this receptor IGF1 activates intracellular signaling cascades that promote anabolic effects which include increased uptake of glucose and amino acids contributing to muscle and tissue growth.

Pathways

IGF1 operates within the PI3K-Akt and MAPK signaling pathways which are significant for cell survival and proliferation. Its interaction with proteins like IGF binding protein 3 (IGFBP3) modulates its availability and activity in the bloodstream. These pathways are critical for mediating the effects of growth hormone highlighting the role of IGF1 in systemic growth and metabolism regulation.

Alterations in IGF1 levels associate with growth abnormalities such as Laron syndrome and acromegaly. Laron syndrome results from the body's inability to use IGF1 properly due to receptor defects while acromegaly occurs from excessive IGF1 production often due to pituitary tumors. Furthermore aberrant IGF1 signaling connects to cancer development where it can drive tumor growth and metastasis. Drugs targeting IGF1 and its pathway components continue to be researched for therapeutic potential in these conditions.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

The insulin-like growth factors, isolated from plasma, are structurally and functionally related to insulin but have a much higher growth-promoting activity. May be a physiological regulator of [1-14C]-2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblasts. Stimulates glucose transport in bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin, not only regarding glycogen and DNA synthesis but also with regard to enhancing glucose uptake. May play a role in synapse maturation (PubMed : 21076856, PubMed : 24132240). Ca(2+)-dependent exocytosis of IGF1 is required for sensory perception of smell in the olfactory bulb (By similarity). Acts as a ligand for IGF1R. Binds to the alpha subunit of IGF1R, leading to the activation of the intrinsic tyrosine kinase activity which autophosphorylates tyrosine residues in the beta subunit thus initiating a cascade of down-stream signaling events leading to activation of the PI3K-AKT/PKB and the Ras-MAPK pathways. Binds to integrins ITGAV : ITGB3 and ITGA6 : ITGB4. Its binding to integrins and subsequent ternary complex formation with integrins and IGFR1 are essential for IGF1 signaling. Induces the phosphorylation and activation of IGFR1, MAPK3/ERK1, MAPK1/ERK2 and AKT1 (PubMed : 19578119, PubMed : 22351760, PubMed : 23243309, PubMed : 23696648). As part of the MAPK/ERK signaling pathway, acts as a negative regulator of apoptosis in cardiomyocytes via promotion of STUB1/CHIP-mediated ubiquitination and degradation of ICER-type isoforms of CREM (By similarity).
See full target information IGF1

Publications (9)

Recent publications for all applications. Explore the full list and refine your search

Saudi medical journal 44:355-362 PubMed37062544

2023

The histopathological effects of sleep disorders on striated muscle in rats.

Applications

Unspecified application

Species

Unspecified reactive species

İlkay Çinar,Muhammed Bozoğlan,Kürşad Aytekin,Deniz Esenyel,Cem Zeki Esenyel

Annals of translational medicine 9:1572 PubMed34790778

2021

Prevention of lumbar disc degeneration through co-manipulation of insulin-like growth factor 1 and vascular endothelial growth factor.

Applications

Unspecified application

Species

Unspecified reactive species

Zuozhou Ye,Shan Zhao,Zuoqing Liu

Journal of molecular neuroscience : MN : PubMed33484421

2021

Inhibition of miR-129 Improves Neuronal Pyroptosis and Cognitive Impairment Through IGF-1/GSK3β Signaling Pathway: An In Vitro and In Vivo Study.

Applications

Unspecified application

Species

Unspecified reactive species

Feng Wang,Lu Wang,Guanghong Sui,Caixia Yang,Mengtian Guo,Xiangyang Xiong,Zheng Chen,Qiang Zhang,Ping Lei

International journal of molecular sciences 20: PubMed31861182

2019

Increase in IGF-1 Expression in the Injured Infraorbital Nerve and Possible Implications for Orofacial Neuropathic Pain.

Applications

Unspecified application

Species

Unspecified reactive species

Shiori Sugawara,Masamichi Shinoda,Yoshinori Hayashi,Hiroto Saito,Sayaka Asano,Asako Kubo,Ikuko Shibuta,Akihiko Furukawa,Akira Toyofuku,Koichi Iwata

The Prostate 78:970-980 PubMed29786867

2018

Growth hormone-releasing hormone antagonists reduce prostatic enlargement and inflammation in carrageenan-induced chronic prostatitis.

Applications

Unspecified application

Species

Unspecified reactive species

Petra Popovics,Renzhi Cai,Wei Sha,Ferenc G Rick,Andrew V Schally

Frontiers in neuroanatomy 12:35 PubMed29867375

2018

A Putative Mechanism of Age-Related Synaptic Dysfunction Based on the Impact of IGF-1 Receptor Signaling on Synaptic CaMKIIα Phosphorylation.

Applications

Unspecified application

Species

Unspecified reactive species

Olalekan M Ogundele,Joaquin Pardo,Joseph Francis,Rodolfo G Goya,Charles C Lee

Neuroscience 353:147-165 PubMed28438613

2017

Stress-altered synaptic plasticity and DAMP signaling in the hippocampus-PFC axis; elucidating the significance of IGF-1/IGF-1R/CaMKIIα expression in neural changes associated with a prolonged exposure therapy.

Applications

WB

Species

Rat

Olalekan M Ogundele,Philip J Ebenezer,Charles C Lee,Joseph Francis

Stem cell research & therapy 8:55 PubMed28279229

2017

Human umbilical cord mesenchymal stem cells improve the reserve function of perimenopausal ovary via a paracrine mechanism.

Applications

IHC, WB

Species

Unspecified reactive species, Unspecified reactive species

Jia Li,QiuXian Mao,JingJun He,HaoQing She,Zhi Zhang,ChunYan Yin

Gene therapy 22:610-8 PubMed25840275

2015

Use of ultrasound-targeted microbubble destruction to transfect IGF-1 cDNA to enhance the regeneration of rat wounded Achilles tendon in vivo.

Applications

Unspecified application

Species

Unspecified reactive species

Y Tang,Q Leng,X Xiang,L Zhang,Y Yang,L Qiu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com